Koenig Scott
Transaction: 05/19/2026
BUY
Change
+3,750
Price
Not reported
Filing
05/20/2026
Type
BUY
MacroGenics, Inc.
MGNX • Biotechnology
$4.40
▲ +0.15 (+3.53%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$279.18M
Growth
-0.7%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 17.0%Healthy liquidity · 5.1Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 13, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:57 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.40
Change3.53%
Shares Out63.45M
Market Cap$279.18M
Enterprise Value$161.46M
52W Range1.29 - 5.08
Beta1.22
P/E-3.97
P/S1.78
P/B13.17
P/FCF-3.89
EV/Sales1.03
Price$4.40
Change3.53%
Shares Out63.45M
Market Cap$279.18M
Enterprise Value$161.46M
52W Range1.29 - 5.08
Beta1.22
P/E-3.97
P/S1.78
P/B13.17
P/FCF-3.89
EV/Sales1.03
EV/EBITDA-2.85
EV/FCF-2.25
Earnings Yield-25.20%
FCF Yield-25.68%
Dividend Yield0.00%
Gross Margin71.12%
Oper. Margin-48.72%
Profit Margin-49.91%
Debt/Eq1.92
Current Ratio5.10
Quick Ratio4.92
Revenue 5Y-0.65%
Target$6.00
Target Upside36.36%
Target Median$6.00
Target Range6.00 - 6.00
Volume1.37M
Avg Volume1.04M
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
53
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
92/100
Why this score▼
Positive revenue growth · 17.0%Healthy liquidity · 5.1Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 22 analyst votes · 2026-09-05
75/100
Bullish
Bullish
12
Hold
9
Bearish
1
Price Target
2026-08-14
Low
$6.00
Mean
$6.00
Median
$6.00
High
$6.00
Insider Transactions
Recent executive and insider activity
Koenig Scott
Transaction: 05/19/2026
BUY
Change
+22,000
Price
$4.52
Filing
05/20/2026
Type
BUY
Ferrante Karen Jean
Transaction: 05/19/2026
BUY
Change
+3,750
Price
Not reported
Filing
05/20/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Koenig Scott | BUY | +3,750 | Not reported | 05/19/2026 | 05/20/2026 |
| Koenig Scott | BUY | +22,000 | $4.52 | 05/19/2026 | 05/20/2026 |
| Ferrante Karen Jean | BUY | +3,750 | Not reported | 05/19/2026 | 05/20/2026 |
| Ferrante Karen Jean | BUY | +22,000 | $4.52 | 05/19/2026 | 05/20/2026 |
| STUMP DAVID C | BUY | +3,750 | Not reported | 05/19/2026 | 05/20/2026 |
| STUMP DAVID C | BUY | +22,000 | $4.52 | 05/19/2026 | 05/20/2026 |
| HURWITZ EDWARD | BUY | +3,750 | Not reported | 05/19/2026 | 05/20/2026 |
| HURWITZ EDWARD | BUY | +22,000 | $4.52 | 05/19/2026 | 05/20/2026 |
| Chhabra Meenu | BUY | +3,750 | Not reported | 05/19/2026 | 05/20/2026 |
| Chhabra Meenu | BUY | +22,000 | $4.52 | 05/19/2026 | 05/20/2026 |
| Liu Margaret | BUY | +3,750 | Not reported | 05/19/2026 | 05/20/2026 |
| Liu Margaret | BUY | +22,000 | $4.52 | 05/19/2026 | 05/20/2026 |
| HEIDEN WILLIAM K | BUY | +3,750 | Not reported | 05/19/2026 | 05/20/2026 |
| HEIDEN WILLIAM K | BUY | +22,000 | $4.52 | 05/19/2026 | 05/20/2026 |
| Jackson Scott Thomas | BUY | +3,750 | Not reported | 05/19/2026 | 05/20/2026 |
| Jackson Scott Thomas | BUY | +22,000 | $4.52 | 05/19/2026 | 05/20/2026 |
| O'Brien Federica F. | BUY | +3,750 | Not reported | 05/19/2026 | 05/20/2026 |
| O'Brien Federica F. | BUY | +22,000 | $4.52 | 05/19/2026 | 05/20/2026 |
| Ferrante Karen Jean | SELL | -3,750 | Not reported | 05/18/2026 | 05/20/2026 |
| Ferrante Karen Jean | BUY | +3,750 | Not reported | 05/18/2026 | 05/20/2026 |